TD Securities (USA)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $7K | Hold |
51
| – | – | 0.06% | 146 |
|
|
2015
Q4 | $10K | Sell |
51
-78
| -60% | -$15.3K | 0.09% | 102 |
|
|
2015
Q3 | $20K | Sell |
129
-90,549
| -100% | -$14M | 0.18% | 125 |
|
|
2015
Q2 | $16.4M | Buy |
90,678
+18,058
| +25% | +$3.26M | 0.22% | 111 |
|
|
2015
Q1 | $12.6M | Sell |
72,620
-2,676
| -4% | -$464K | 0.19% | 127 |
|
|
2014
Q4 | $13.9M | Buy |
75,296
+6,102
| +9% | +$1.13M | 0.2% | 122 |
|
|
2014
Q3 | $11.5M | Buy |
69,194
+48
| +0.1% | +$7.96K | 0.19% | 131 |
|
|
2014
Q2 | $10.8M | Buy |
69,146
+4,226
| +7% | +$660K | 0.17% | 147 |
|
|
2014
Q1 | $9.88M | Sell |
64,920
-4,257
| -6% | -$648K | 0.18% | 141 |
|
|
2013
Q4 | $9.21M | Buy |
69,177
+2,221
| +3% | +$296K | 0.16% | 158 |
|
|
2013
Q3 | $7.78M | Buy |
66,956
+416
| +0.6% | +$48.3K | 0.15% | 164 |
|
|
2013
Q2 | $6.14M | Buy |
+66,540
| New | +$6.14M | 0.12% | 198 |
|